Article Correctness Is Author's Responsibility: Alemtuzumab Improves Disability, Prognosis in Treatment-Refractory MS

The article below may contain offensive and/or incorrect content.

Study investigators assessed the changes in the Expanded Disability Status Scale and MS Severity Score after up to 7 courses of alemtuzumab.